Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
symbols : CCXI save search
Immuneering Appoints Thomas J. Schall, Ph.D. to its Board of Directors
Published: 2024-03-12 (Crawled : 12:00) - globenewswire.com
IMRX | $1.66 -6.22% 360K
|
|
| O: 0.59%
H: 4.02%
C: -1.93%
AMGEN PRESENTS NEW RESEARCH ON OTEZLA® (APREMILAST) AT AAD 2024
Published: 2024-03-09 (Crawled : 20:20) - prnewswire.com
BEIGF | $14.29 -9.87% 2.1K
|
n/a
| Email alert
Add to watchlist
CCXI | $51.99 -0.04%
|
Health Technology
| Email alert
Add to watchlist
BGNE | $129.995 -1.49% 110K
|
Health Technology
| Email alert
Add to watchlist
AMGN | $267.41 1.77% 1.4M
|
Health Technology
| Email alert
Add to watchlist
otezla research
AMGEN ANNOUNCES 2024 SECOND QUARTER DIVIDEND
Published: 2024-03-06 (Crawled : 21:00) - prnewswire.com
BGNE | $129.995 -1.49% 110K
|
Health Technology
|
| O: -0.93%
H: 3.2%
C: 2.66%
AMGN | $267.41 1.77% 1.4M
|
Health Technology
|
| O: -0.1%
H: 0.18%
C: -1.25%
AMGEN OPENS STATE-OF-THE-ART BIOMANUFACTURING SITE IN CENTRAL OHIO
Published: 2024-02-26 (Crawled : 14:00) - prnewswire.com
BGNE | $129.995 -1.49% 110K
|
Health Technology
|
| O: 2.6%
H: 1.87%
C: 0.7%
AMGN | $267.41 1.77% 1.4M
|
Health Technology
|
| O: -0.31%
H: 0.55%
C: -0.66%
AMGEN REPORTS FOURTH QUARTER AND FULL YEAR 2023 FINANCIAL RESULTS
Published: 2024-02-06 (Crawled : 21:00) - prnewswire.com
BMY | $48.89 1.22% 5.1M
|
Health Technology
|
| O: -0.14%
H: 0.35%
C: -1.12%
XNCR | $18.325 -3.3% 220K
|
Health Technology
|
| O: -0.05%
H: 0.0%
C: -2.09%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: 1.33%
H: 0.0%
C: 0.0%
BGNE | $129.995 -1.49% 110K
|
Health Technology
|
| O: -3.53%
H: 1.53%
C: -0.27%
AMGN | $267.41 1.77% 1.4M
|
Health Technology
|
| O: -0.18%
H: 0.0%
C: -6.22%
year financial results
AMGEN PROVIDES REGULATORY UPDATE ON STATUS OF LUMAKRAS® (SOTORASIB)
Published: 2023-12-26 (Crawled : 14:00) - prnewswire.com
BGNE | $129.995 -1.49% 110K
|
Health Technology
|
| O: 0.36%
H: 1.17%
C: -0.59%
AMGN | $267.41 1.77% 1.4M
|
Health Technology
|
| O: -0.01%
H: 0.21%
C: -0.08%
lumakras update
FDA Grants Priority Review to Amgen's Tarlatamab Application for Advanced Small Cell Lung Cancer
Published: 2023-12-13 (Crawled : 21:00) - prnewswire.com
BGNE | $129.995 -1.49% 110K
|
Health Technology
|
| O: 0.91%
H: 2.03%
C: 1.4%
AMGN | $267.41 1.77% 1.4M
|
Health Technology
|
| O: -0.11%
H: 0.5%
C: -1.78%
fda lung review cancer cell application grants advanced
AMGEN ANNOUNCES 2024 FIRST QUARTER DIVIDEND INCREASE TO $2.25 PER SHARE
Published: 2023-12-12 (Crawled : 21:00) - prnewswire.com
BGNE | $129.995 -1.49% 110K
|
Health Technology
|
| O: 0.25%
H: 2.68%
C: 1.83%
AMGN | $267.41 1.77% 1.4M
|
Health Technology
|
| O: 0.06%
H: 2.8%
C: 2.72%
first
AMGEN HIGHLIGHTS HEMATOLOGY PORTFOLIO AT ASH 2023
Published: 2023-12-08 (Crawled : 14:00) - prnewswire.com
BGNE | $129.995 -1.49% 110K
|
Health Technology
|
| O: -1.32%
H: 0.78%
C: -1.13%
AMGN | $267.41 1.77% 1.4M
|
Health Technology
|
| O: -0.05%
H: 0.3%
C: -0.76%
AMGEN PRESENTS NEW CARDIOVASCULAR RESEARCH AT AHA 2023
Published: 2023-11-10 (Crawled : 14:00) - prnewswire.com
BGNE | $129.995 -1.49% 110K
|
Health Technology
|
| O: 2.63%
H: 2.5%
C: 2.35%
AMGN | $267.41 1.77% 1.4M
|
Health Technology
|
| O: 0.98%
H: 0.49%
C: 0.25%
research cardiovascular
AMGEN PRESENTS NEW RESEARCH IN EARLY PSORIATIC ARTHRITIS AT ACR 2023
Published: 2023-11-07 (Crawled : 21:00) - prnewswire.com
BGNE | $129.995 -1.49% 110K
|
Health Technology
|
| O: 0.66%
H: 1.5%
C: 0.61%
AMGN | $267.41 1.77% 1.4M
|
Health Technology
|
| O: 0.48%
H: 0.86%
C: 0.31%
research
AMGEN PRESENTS NEW DATA THAT SHOW BLOOD PRESSURE DECREASES FOR ADULTS TREATED WITH KRYSTEXXA® (PEGLOTICASE)
Published: 2023-11-02 (Crawled : 14:00) - biospace.com/
BGNE | $129.995 -1.49% 110K
|
Health Technology
|
| O: 0.5%
H: 2.69%
C: -0.09%
AMGN | $267.41 1.77% 1.4M
|
Health Technology
|
| O: 0.94%
H: 1.82%
C: 1.25%
krystexxa blood show
AMGEN TO PRESENT DATA AT ACR 2023 ACROSS EXPANDED RHEUMATOLOGY PIPELINE AND PORTFOLIO
Published: 2023-11-01 (Crawled : 20:00) - biospace.com/
BGNE | $129.995 -1.49% 110K
|
Health Technology
|
| O: -1.12%
H: 1.26%
C: -1.57%
AMGN | $267.41 1.77% 1.4M
|
Health Technology
|
| O: 0.22%
H: 1.92%
C: 1.78%
pipeline
AMGEN REPORTS THIRD QUARTER FINANCIAL RESULTS
Published: 2023-10-31 (Crawled : 11:00) - prnewswire.com
SNYNF | News | $92.7 600K
|
Health Technology
|
| O: 4.66%
H: 0.0%
C: -3.51%
BMY | $48.89 1.22% 5.1M
|
Health Technology
|
| O: 0.25%
H: 0.54%
C: 0.29%
XNCR | $18.325 -3.3% 220K
|
Health Technology
|
| O: -0.41%
H: 2.1%
C: 1.11%
SNY | News | $46.545 2.55% 2.3M
|
Health Technology
|
| O: 2.61%
H: 0.0%
C: 0.0%
REGN | $893.67 -0.04% 230K
|
Health Technology
|
| O: -0.33%
H: 0.92%
C: 0.61%
BGNE | $129.995 -1.49% 110K
|
Health Technology
|
| O: 0.14%
H: 0.68%
C: -0.32%
AMGN | $267.41 1.77% 1.4M
|
Health Technology
|
| O: -2.77%
H: 0.6%
C: -0.07%
financial results
AMGEN ANNOUNCES 2023 FOURTH QUARTER DIVIDEND
Published: 2023-10-24 (Crawled : 20:00) - prnewswire.com
BGNE | $129.995 -1.49% 110K
|
Health Technology
|
| O: -2.79%
H: 2.0%
C: -0.98%
AMGN | $267.41 1.77% 1.4M
|
Health Technology
|
| O: -0.37%
H: 0.58%
C: -1.07%
AMGEN PRESENTS NEW LUMAKRAS® (SOTORASIB) PLUS VECTIBIX® (PANITUMUMAB) DATA IN PATIENTS WITH KRAS G12C-MUTATED METASTATIC COLORECTAL CANCER
Published: 2023-10-22 (Crawled : 16:20) - prnewswire.com
CCXI | $51.99 -0.04%
|
Health Technology
| Email alert
Add to watchlist
AMGN | $267.41 1.77% 1.4M
|
Health Technology
| Email alert
Add to watchlist
BGNE | $129.995 -1.49% 110K
|
Health Technology
| Email alert
Add to watchlist
BEIGF | $14.29 -9.87% 2.1K
|
n/a
| Email alert
Add to watchlist
lumakras cancer plus
AMGEN PRESENTS NEW TARLATAMAB DATA IN SMALL CELL LUNG CANCER
Published: 2023-10-20 (Crawled : 12:00) - prnewswire.com
BGNE | $129.995 -1.49% 110K
|
Health Technology
|
| O: -1.33%
H: 5.87%
C: 5.53%
AMGN | $267.41 1.77% 1.4M
|
Health Technology
|
| O: 0.0%
H: 0.16%
C: -0.64%
lung cancer cell
AMGEN TO PRESENT NEW RESEARCH FROM ONCOLOGY PORTFOLIO AND PIPELINE AT ESMO 2023
Published: 2023-10-16 (Crawled : 18:00) - biospace.com/
XNCR | $18.325 -3.3% 220K
|
Health Technology
|
| O: 0.0%
H: 1.49%
C: 0.53%
BGNE | $129.995 -1.49% 110K
|
Health Technology
|
| O: -3.15%
H: 2.37%
C: 0.45%
AMGN | $267.41 1.77% 1.4M
|
Health Technology
|
| O: 0.14%
H: 1.16%
C: 0.84%
pipeline research
AMGEN COMPLETES ACQUISITION OF HORIZON THERAPEUTICS PLC
Published: 2023-10-06 (Crawled : 12:30) - prnewswire.com
BGNE | $129.995 -1.49% 110K
|
Health Technology
|
| O: 1.62%
H: 1.06%
C: 0.25%
AMGN | $267.41 1.77% 1.4M
|
Health Technology
|
| O: -0.73%
H: 2.07%
C: 1.64%
acquisition therapeutics
AMGEN LAUNCHES PARTNERS OF CHOICE NETWORK OF EIGHT LEADING ONCOLOGY ACADEMIC CENTERS
Published: 2023-09-20 (Crawled : 20:00) - prnewswire.com
BGNE | $129.995 -1.49% 110K
|
Health Technology
|
| O: -2.14%
H: 0.25%
C: -0.49%
AMGN | $267.41 1.77% 1.4M
|
Health Technology
|
| O: 0.22%
H: 0.15%
C: -0.98%
network
Gainers vs Losers
| 71% | 29% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.0503 39.72% 320M
|
RWOD | $10.52 31.56% 5.9M
|
n/a
ZCMD | $1.905 31.38% 30M
|
Commercial Services
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
TPET | $0.4121 25.68% 45M
|
n/a
NVFY | $2.65 25.59% 33M
|
Consumer Durables
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.